MetLife Investment Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.05M Sell
32,395
-19
-0.1% -$1.2K 0.01% 977
2025
Q1
$1.72M Sell
32,414
-1,084
-3% -$57.4K 0.01% 1114
2024
Q4
$1.88M Buy
33,498
+1,846
+6% +$103K 0.01% 1080
2024
Q3
$1.66M Hold
31,652
0.01% 1122
2024
Q2
$1.3M Buy
31,652
+4,529
+17% +$186K 0.01% 1208
2024
Q1
$1.18M Hold
27,123
0.01% 1214
2023
Q4
$1.25M Hold
27,123
0.01% 1182
2023
Q3
$622K Hold
27,123
﹤0.01% 1491
2023
Q2
$447K Buy
+27,123
New +$447K ﹤0.01% 1769
2022
Q2
Sell
-24,442
Closed -$282K 2900
2022
Q1
$282K Buy
24,442
+9,070
+59% +$104K ﹤0.01% 2130
2021
Q4
$153K Hold
15,372
﹤0.01% 2214
2021
Q3
$201K Hold
15,372
﹤0.01% 2099
2021
Q2
$301K Hold
15,372
﹤0.01% 1886
2021
Q1
$327K Hold
15,372
﹤0.01% 1763
2020
Q4
$457K Hold
15,372
﹤0.01% 1530
2020
Q3
$333K Hold
15,372
﹤0.01% 1579
2020
Q2
$343K Buy
15,372
+1,907
+14% +$42.5K ﹤0.01% 1584
2020
Q1
$205K Hold
13,465
﹤0.01% 1682
2019
Q4
$309K Buy
13,465
+2,209
+20% +$50.7K ﹤0.01% 1727
2019
Q3
$243K Hold
11,256
﹤0.01% 1836
2019
Q2
$248K Buy
11,256
+5,064
+82% +$111K ﹤0.01% 1904
2019
Q1
$170K Hold
6,192
﹤0.01% 2060
2018
Q4
$166K Hold
6,192
﹤0.01% 2006
2018
Q3
$181K Buy
+6,192
New +$181K ﹤0.01% 2143
2018
Q1
Sell
-9,862
Closed -$287K 2213
2017
Q4
$287K Buy
+9,862
New +$287K ﹤0.01% 1735